does semaglutide cause rash at Injection Site: Causes, Management & Prevention Hypersensitivity to glucagon‐like peptide‐1 receptor

doi: 10.1038/s41467-019-09101-4 118 LagaresDSantosAGrasbergerPELiuFProbstCKRahimiRAet al

Weight loss injections, primarily glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and tirzepatide (Zepbound), function through multiple physiological mechanisms that reduce body weight

*Individual before and after results may vary

To view a copy of this licence, visit About this article Cite this article McCrimmon, R.J., Catarig, AM., Frias, J.P

According to the World Health Organization, around 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to diabetes each year